Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: Jul 15, 2025 · CIK: 882361
Sentiment: neutral
Topics: 8-K, disclosure, financial-reporting
Related Tickers: APTO
TL;DR
APTO filed an 8-K on 7/15/25, check for updates.
AI Summary
Aptose Biosciences Inc. filed an 8-K on July 15, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and operates in the biological products sector.
Why It Matters
This filing provides important updates and disclosures for investors regarding Aptose Biosciences Inc.'s regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, indicating standard corporate disclosures rather than a specific event with immediate high risk.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report under Regulation FD and to include financial statements and exhibits as of July 15, 2025.
When was Aptose Biosciences Inc. previously known by other names?
Aptose Biosciences Inc. was formerly known as Lorus Therapeutics Inc. (name change effective September 5, 2014) and Imutec Pharma Inc (name change effective January 13, 1997).
In which jurisdiction is Aptose Biosciences Inc. incorporated?
Aptose Biosciences Inc. is incorporated in Canada.
What is the Standard Industrial Classification (SIC) code for Aptose Biosciences Inc.?
The SIC code for Aptose Biosciences Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the filing date for this 8-K report?
The filing date for this 8-K report is July 15, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding Aptose Biosciences Inc. (APTOF).